When government officials and politicians scrutinize high U.S. drug prices, the role of insurers and pharmacy benefit ...

Besides stomach cancer, the FDA also raised a similar concern for PD-1 drugs in first-line esophageal squamous cell carcinoma ...

Flush with new business, Philadelphia-based CDMO PCI Pharma Services is blueprinting multiple manufacturing outlays on both ...

Many people who struggle with weight management may experience an uncontrollable, near-obsessive preoccupation with food. | ...

After bluebird bio acknowledged troubles keeping its business operational, the gene therapy biotech is launching a ...

With the launch of Casgevy gaining momentum, Vertex Pharmaceuticals is adding another link to its gene-editing therapy supply ...

After circling Novo Nordisk and its high GLP-1 drug prices for months, Sen. | Ahead of a hearing on Ozempic and Wegovy prices ...

Three months after a federal judge in West Virginia sided with Regeneron, blocking the market entry of two biosimilars for ...

After several years spent honing its robotic cell therapy manufacturing system, Multiply Labs has snared its first ...

Ahead of a Senate hearing centered on high prices for Novo Nordisk’s in-demand semaglutide medications, lawmakers are ...

Savara says it will in the first of half next year seek an FDA license to treat autoimmune pulmonary alveolar proteinosis ...

As CDMOs across the industry continue to face pressure from a fluctuating biopharma business environment, AGC Biologics is ...